Effect of Adefovir Dipivoxil on the Inhibition of Osteogenic Differentiation of Mesenchymal Stem Cells and Osteoblasts
Adefovir dipivoxil (ADV) is used for the treatment of hepatitis and acquired immunodeficiency syndrome, but long-term use can cause osteoporosis. In this study, the effect of ADV on the osteocyte maturation process was evaluated at the level of undifferentiated cells using mesenchymal stem cells (MS...
Main Author: | Ho PARK |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Society for Clinical Laboratory Science
2023-12-01
|
Series: | Korean Journal of Clinical Laboratory Science |
Subjects: | |
Online Access: | http://www.kjcls.org/journal/view.html?doi=10.15324/kjcls.2023.55.4.284 |
Similar Items
-
Adefovir dipivoxil inhibits APL progression through degradation of the oncoprotein PML-RARA
by: Xubo Gong, et al.
Published: (2022-11-01) -
Low-dose adefovir dipivoxil–induced hypophosphatemia osteomalacia in five chronic hepatitis B virus–infected patients. Is low-dose adefovir dipivoxil–induced nephrotoxicity completely reversible?
by: Qian YY, et al.
Published: (2019-04-01) -
Clinical features of hypophosphatemic osteomalacia induced by long-term low-dose adefovir dipivoxil
by: Zhu S, et al.
Published: (2017-12-01) -
Liquid-Assisted Grinding to Prepare a Cocrystal of Adefovir Dipivoxil Thermodynamically Less Stable than Its Neat Phase
by: Sungyup Jung, et al.
Published: (2015-11-01) -
Adefovir dipivoxil-induced development of osteomalacia and Fanconi syndrome during the treatment of hepatitis B virus (HBV)-related cirrhosis
by: Orietta Staltari, et al.
Published: (2014-12-01)